Page last updated: 2024-10-26

distigmine and Multiple System Atrophy

distigmine has been researched along with Multiple System Atrophy in 1 studies

distigmine : A carbamate ester resulting from the formal condensation of both carboxy groups of hexane-1,6-diylbis(methylcarbamic acid) with the hydroxy group of 3-hydroxy-1-methylpyridinium.

Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, K1
Miyamoto, T1
Miyamoto, M1
Hirata, K1

Other Studies

1 other study available for distigmine and Multiple System Atrophy

ArticleYear
Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy.
    Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:10

    Topics: Cholinesterase Inhibitors; Diffusion Magnetic Resonance Imaging; Humans; Male; Middle Aged; Multiple

2008